Trial record 18 of 64 for:    "male pattern baldness" OR "Androgenetic Alopecia"

Treatment of Male Pattern Baldness With Botulinum Toxin

This study has been completed.
Sponsor:
Information provided by:
The Crown Institute
ClinicalTrials.gov Identifier:
NCT00965640
First received: August 24, 2009
Last updated: NA
Last verified: August 2009
History: No changes posted
  Purpose

This proof of concept study seeks to demonstrate that Botulinum toxin injections are a safe and effective method for treating this form of hair loss.


Condition Intervention Phase
Male Pattern Baldness
Drug: Botulinum Toxin - A injections
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Screening
Official Title: A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia

Resource links provided by NLM:


Further study details as provided by The Crown Institute:

Primary Outcome Measures:
  • Hair Growth [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Hair Loss [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Study Start Date: December 2002
Study Completion Date: June 2004
Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male pattern baldness
  • Norwood II-VI

Exclusion Criteria:

  • Treatment with Botulinum toxins or other hair growth interventions with past year
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00965640

Locations
Canada, Ontario
Crown Institute
Pickering, Ontario, Canada, L1V 1B1
Sponsors and Collaborators
The Crown Institute
Investigators
Principal Investigator: Brian Freund, MD Crown Institute
  More Information

No publications provided by The Crown Institute

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. B. Freund, Principal Investigator, Crown Institute
ClinicalTrials.gov Identifier: NCT00965640     History of Changes
Other Study ID Numbers: MPB-2002-01, HPB 081023
Study First Received: August 24, 2009
Last Updated: August 24, 2009
Health Authority: Canada: Health Canada

Keywords provided by The Crown Institute:
male pattern baldness
androgenetic alopecia
hair loss

Additional relevant MeSH terms:
Alopecia
Alopecia Areata
Hypotrichosis
Hair Diseases
Skin Diseases
Pathological Conditions, Anatomical
Botulinum Toxins, Type A
Botulinum Toxins
Neuromuscular Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Anti-Dyskinesia Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on August 19, 2014